JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (2): 36-39.doi: 10.6040/j.issn.1673-3770.1.2016.10

Previous Articles     Next Articles

Treatment advance of secondary hyperthyroidism.

CHEN Jun, WANG Jiadong   

  1. Department of Otolaryngology, Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai 200001, China
  • Received:2016-03-10 Online:2016-04-16 Published:2016-04-16

PDF (PC)

606

Abstract: Secondary hyperparathyroidism(SHPT)is a common complication of metabolic disorders in chronic kidney disease(CKD)patients. The Incidence of SHPT has increased with the passing years and the clinical manifestations are increased parathyroid hormone level, calcium-phosphorus metabolic disorders and bone pain, et al. In addition to the familiar factors, such as serum calcium and phosphorus, vitamin D and its receptor, calcium-sensing receptors, the mechanism for CKD-SHPT also includes the molecular and cellular mechanism, such as peptidyl-prolyl cis-trans isomerase 1(Pin1), Klotho protein and fibroblast growth factor-23(FGF23). Nowadays, the therapeutic strategy is mainly focused on medication, surgery and interventional therapy. This review will also introduce the pre-operation localization methods and surgical methods. Its critical to choose the suitable surgical methods for SHPT treatment.

Key words: Localization, Secondary hyperparathyroidism, Treatment

CLC Number: 

  • R582.2
[1] Slatopolsky E, Bown A, Dusso A. Role of phosphorus in pathogenesis of secondary hyperparathyroidism[J]. Am J Kidney Dis, 2001, 37:S54-S57.
[2] 孙鲁英,王梅,杨莉. 终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J]. 北京大学学报(医学版), 2005, 37(2):36-39. SNU Luying, WANG Mei, YANG Li. Study of calcium-phosphorous metabolism and intact parathyroid hormone levels in end stage renal disease patients[J]. J Peking Univ(Health Sci), 2005, 37(2):36-39.
[3] 贾彦诺,高志华,徐然东,等. 慢性肾衰竭继发性甲状旁腺功能亢进的相关因素分析及治疗[J]. 中国老年学杂志, 2015, 35(11):3182-3184.
[4] Nechama M, Uchida T, Mor Yosef-Levi I, et al. The peptidylprolyl isomerase Pin1 determines parathyroid hommne mRNA levels and stability in rat models of secondary hyperparathyroidism[J]. J Clin Invest, 2009, 119(10):3102-3114.
[5] 赵玉,张丽丽,曹平, 等.PIN1基因启动子区-667C>T多态性与慢性肾脏病伴继发性甲状旁腺功能亢进的相关性[J].肾脏病与透析肾移植杂志,2013,22(6):513-519. ZHAO Yu, ZHANG Lili, CAO Ping, et al. Correlation of PIN1 gene promoter region-667C > T polymorphism with secondary hyperparathyroidism of chronic kidney disease[J]. Chin J Nephrol Dialysis Transplant, 2013, 22(6):513-519.
[6] Komaba H, Fukagawa M. FGF23-Parathyroid interaction:implications in chronic kidney disease[J]. Kidney Int, 2010, 77(4):292-298.
[7] Kuro-o M. Klotho in health and disease[J]. Curr Opin Nephrol Hypertens, 2012, 21(4):362 -368.
[8] 冯嘉麟, 周秦毅, 陈隽, 等. 继发性甲状旁腺功能亢进外科治疗的疗效分析[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(8):661-667. FENG Jialin, ZHOU Qinyi, CHEN Jun, et al. Therapeutic evaluation of surgical procedure in treatment of secondary hyperparathyroidism[J]. Chin J Otorhinolaryngol Head Neck Surg, 2015, 50(8):661-667.
[9] Parfrey P S, Drüeke T B, Block G A, et al. The effects of cinacalcet in older and younger patients on hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events(EVOLVE)trial[J]. Clin J Am Soc Nephrol, 2015, 10(5):791-799.
[10] Perry C M, Plosker G L. Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease[J]. Drugs, 2014, 74(7):771-792.
[11] Hutchison A J, Barnett M E, Krause R, et al. Long- term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment[J]. Nephron Clin Pract, 2008, 110(1):c15-23.
[12] Lund R J, Andress D L, Amdahl M, et al. Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients[J]. Am J Nephrol, 2010, 31(2):165-170.
[13] Jun Chen, Jia-dong Wang. Radioguided parathyroidectomy in patients with secondary hyperparathyroidism due to chronic renal failure[J]. Nuclear Medicine Communications, 2014, 35:391-397.
[14] Johnson N A, Carty S E, Tublin M E. Parathyroid imaging[J]. Radiol Clin North Am, 2011, 49(3):489-509.
[15] 张庆,张青.甲状旁腺显像存在的问题及进展[J]. 江西医药,2006,41(11):920-921.
[16] 周建平,李昱骥,董明, 等. 原发性甲状旁腺功能亢进的定位诊断[J].中华普通外科杂志,2005,14(9):227-228. ZHOU Jianping, LI Yuji, DONG Ming, et al.Localizing diagnosis of primary hyperparathyroidism[J]. Chin J Gen Surgery, 2005, 14(9):227-228.
[17] Chen H, Sippel R S, Schaefer S. The effectiveness of radioguided parathyroidectomy in patients with negative technetium Tc 99m-sestamibi scan[J]. Arch Surg, 2009, 144(7):643-648.
[18] Harris R, Ryu H, Vu T, et al. Modern approach to surgical intervention of the thyroid and parathyroid glands[J]. Semin Ultrasound CT MR, 2012, 3(2):115-122.
[19] Richards M L, Wormuth J, Bingener J, et al. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management?[J]. Surgery, 2006, 139(2):174-180.
[20] Shih M L, Duh Q Y, Hsieh C B, et al. Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism[J]. World J Surg, 2009, 33(2):248-254.
[21] Chen J, Zhou Q Y, Wang J D. Comparison between subtotal parathyroidectomy and total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in patients with chronic renal failure: a meta-analysis[J]. Horm Metab Res, 2015, 47(9):643-651.
[22] Agha A, Loss M, Schlitt H J, et al. Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects[J]. Eur Arch Otorhinolaryngol, 2012, 269(5):1519-1525.
[23] Goldstein R E, Billheimer D, Martin W H, et al. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement[J]. Ann Surg, 2003, 237(5):722-730.
[24] Rubello D, Giannini S, Martini C, et al. Minimally invasive radio-guided parathyroidectomy[J]. Biomed Pharmacother, 2006, 60(3):134-138.
[25] Cayo A, Chen H. Radioguided reoperative parathyroidectomy for persistent primary hyperparathyroidism[J]. Clin Nucl Med, 2008, 33(10):668-670.
[26] Fujii T, Yajima R, Yamaguchi S, et al. Could the eZ-SCOPE AN gamma camera replace intraoperative measurement of iPTH for PHPT?[J]. Inter Surgery, 2012, 97(2):99-103.
[27] Gencoglu E A, Aktas A. The efficacy of low and high dose(99m)Tc-MIBI protocols for intraoperative identification of hyperplastic parathyroid glands in secondary hyperparathyroidism[J]. Rev Esp Med Nucl Imagen Mol, 2014, 33(4):210-214.
[28] 张凌. 继发性甲状旁腺功能亢进的治疗策略[J]. 中华肾病研究电子杂志, 2015, 4(3):5-9. ZHANG Ling. Strategy for the treatment of secondary hyperparathyroidism[J]. Chin J Kid Dis Invest(Electr Ver), 2015, 4(3):5-9.
[1] SHEN Qinfeng, SHEN Xiaoyan, ZHU Rongqiang, JIANG Feifei, LANG Juntian. Role of functional middle turbinectomy in functional endoscopic sinus surgery for chronic sinusitis [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 82-85.
[2] DAI Yacuo, LI Jing, WAN Baoluo, ZANG Yanzi, HUANG Yingming. Individualized treatment of pharyngeal and laryngeal cavernous hemangioma:a report of two cases. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 110-112.
[3] LIU Yiping, LIN Yuanchao. Use of negative pressure drainage for prevention of salivary fistula after parotidectomy: an analysis of 112 cases [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 65-67.
[4] ZHANG Guimin, LIN Peng. Endotype of chronic rhinosinusitis: from basic to clinical research [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 14-17.
[5] WANG Xian, LI Ying, ZHAO Bojun. Advances in diagnosis and treatment of polypoid choroidal vasculopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 103-106.
[6] GAO Jinliang, NIAN Wanqing, LI Shuo. Evaluation of the clinical curative effect of nose surgery in combination with nasal corticosteroids in [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 38-42.
[7] LÜ Dan, LI Mingxia, MA Lanzhi, ZHANG Xinyuan, XIAO Hao, CHEN Fei, LIU Jun, LI Zhen. Neurofibromatosis of the head and neck involving the mediastinum: two cases report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 82-86.
[8] CHEN Hong, CAO Huiling, DOU Xin, GAO Xia. Small cell neuroendocrine carcinoma in the right nasal cavity: a report of one case and a literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 89-92.
[9] SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben. Standardization of the diagnosis and treatment of anaplastic thyroid carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 16-20.
[10] JING Shanglin.. Diagnosis and treatment of upper airway cough syndrome in children. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 87-91.
[11] ZHANG Yubo, YUE Liyan, YIN Xiaoyan, LÜ Zhe, SHAN Chunguang. Effect of tinnitus treatment instrument combined with Ginkgo biloba extract on hearing and hemorheology in patients with sudden deafness and tinnitus. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 50-53.
[12] MA Zhaoen, ZHAI Jinming, LIAO Libing, YANG Zhen. Short-term effect of eustachian tube balloon dilation in the treatment of chronic otitis media with effusion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 54-56.
[13] PAN Yongjie, SUN Guochen, ZANG Chuanshan. Granular cell tumor in the larynx: a report of four cases and a literature review. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 104-106.
[14] LIU Jing. Treatment of allergic rhinitis using syndrome differentiation based on the concept of “holism” in TCM. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 28-30.
[15] JIE Ying, LU Hongshuang. Allergic conjunctivitis: diagnosis and treatment. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 31-36.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd